TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00385	Homocarnosinosis	8.14498283620258e-05	-9.41552333019866	22	8	0.10958904109589	73	992	2729,55191,8659,2875,2673,2937,2571,55577	GCLC,NADSYN1,ALDH4A1,GPT,GFPT1,GSS,GAD1,NAGK
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	8.14498283620258e-05	-9.41552333019866	22	8	0.10958904109589	73	992	2729,55191,2673,2937,8659,2875,2571,55577	GCLC,NADSYN1,GFPT1,GSS,ALDH4A1,GPT,GAD1,NAGK
SMP00567	Succinic semialdehyde dehydrogenase deficiency	8.14498283620258e-05	-9.41552333019866	22	8	0.10958904109589	73	992	55577,2571,2937,2673,2875,8659,55191,2729	NAGK,GAD1,GSS,GFPT1,GPT,ALDH4A1,NADSYN1,GCLC
SMP00072	Glutamate Metabolism	8.14498283620258e-05	-9.41552333019866	22	8	0.10958904109589	73	992	55191,2729,2937,2673,8659,2875,2571,55577	NADSYN1,GCLC,GSS,GFPT1,ALDH4A1,GPT,GAD1,NAGK
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	8.14498283620258e-05	-9.41552333019866	22	8	0.10958904109589	73	992	2729,55191,55577,2571,2937,2673,2875,8659	GCLC,NADSYN1,NAGK,GAD1,GSS,GFPT1,GPT,ALDH4A1
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	8.14498283620258e-05	-9.41552333019866	22	8	0.10958904109589	73	992	8659,2875,2673,2937,2571,55577,2729,55191	ALDH4A1,GPT,GFPT1,GSS,GAD1,NAGK,GCLC,NADSYN1
SMP00013	Cysteine Metabolism	0.0232779477101266	-3.76024881678644	9	3	0.0410958904109589	73	992	2805,2729,4357	GOT1,GCLC,MPST
SMP00722	Cystinosis- ocular nonnephropathic	0.0232779477101266	-3.76024881678644	9	3	0.0410958904109589	73	992	2805,2729,4357	GOT1,GCLC,MPST
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	0.0232779477101266	-3.76024881678644	9	3	0.0410958904109589	73	992	2805,2729,4357	GOT1,GCLC,MPST
SMP00045	Amino Sugar Metabolism	0.0308432483352192	-3.47883740719492	17	4	0.0547945205479452	73	992	2673,3073,10020,55577	GFPT1,HEXA,GNE,NAGK
SMP00390	Tay-Sachs Disease	0.0308432483352192	-3.47883740719492	17	4	0.0547945205479452	73	992	10020,55577,3073,2673	GNE,NAGK,HEXA,GFPT1
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	0.0308432483352192	-3.47883740719492	17	4	0.0547945205479452	73	992	2673,10020,55577,3073	GFPT1,GNE,NAGK,HEXA
SMP00217	Sialuria or French Type Sialuria	0.0308432483352192	-3.47883740719492	17	4	0.0547945205479452	73	992	2673,10020,55577,3073	GFPT1,GNE,NAGK,HEXA
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	0.0308432483352192	-3.47883740719492	17	4	0.0547945205479452	73	992	2673,3073,10020,55577	GFPT1,HEXA,GNE,NAGK
SMP00216	Sialuria or French Type Sialuria	0.0308432483352192	-3.47883740719492	17	4	0.0547945205479452	73	992	10020,55577,3073,2673	GNE,NAGK,HEXA,GFPT1
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	0.0315216937357634	-3.45707928016447	10	3	0.0410958904109589	73	992	3032,1376,2180	HADHB,CPT2,ACSL1
SMP00643	Pancreas Function	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	782,773	CACNB1,CACNA1A
SMP00460	Glibenclamide Action Pathway	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	773,782	CACNA1A,CACNB1
SMP00461	Gliclazide Action Pathway	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	773,782	CACNA1A,CACNB1
SMP00517	Carnitine-acylcarnitine translocase deficiency	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	1376,2180	CPT2,ACSL1
SMP00454	Repaglinide Action Pathway	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	773,782	CACNA1A,CACNB1
SMP00516	Adrenoleukodystrophy- X-linked	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	2180,1376	ACSL1,CPT2
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	1376,2180	CPT2,ACSL1
SMP00453	Nateglinide Action Pathway	0.0461958358683323	-3.07486561767672	5	2	0.0273972602739726	73	992	773,782	CACNA1A,CACNB1
SMP00543	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.0519540195286532	-2.95739619140495	12	3	0.0410958904109589	73	992	4524,1719,10840	MTHFR,DHFR,ALDH1L1
SMP00053	Folate Metabolism	0.0519540195286532	-2.95739619140495	12	3	0.0410958904109589	73	992	4524,1719,10840	MTHFR,DHFR,ALDH1L1
SMP00724	Folate malabsorption- hereditary	0.0519540195286532	-2.95739619140495	12	3	0.0410958904109589	73	992	1719,10840,4524	DHFR,ALDH1L1,MTHFR
SMP00432	Methotrexate Action Pathway	0.0519540195286532	-2.95739619140495	12	3	0.0410958904109589	73	992	4524,10840,1719	MTHFR,ALDH1L1,DHFR
SMP00308	Dopamine Activation of Neurological Reward System	0.0660365569881389	-2.71754679653856	6	2	0.0273972602739726	73	992	2778,1812	GNAS,DRD1
SMP00541	Carnitine palmitoyl transferase deficiency (II)	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	3032,2180,1376	HADHB,ACSL1,CPT2
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	1376,2180,3032	CPT2,ACSL1,HADHB
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	1376,2180,3032	CPT2,ACSL1,HADHB
SMP00051	Fatty acid Metabolism	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	2180,1376,3032	ACSL1,CPT2,HADHB
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	1376,2180,3032	CPT2,ACSL1,HADHB
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	3032,2180,1376	HADHB,ACSL1,CPT2
SMP00545	Trifunctional protein deficiency	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	2180,1376,3032	ACSL1,CPT2,HADHB
SMP00185	Glutaric Aciduria Type I	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	3032,1376,2180	HADHB,CPT2,ACSL1
SMP00181	Ethylmalonic Encephalopathy	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	3032,1376,2180	HADHB,CPT2,ACSL1
SMP00538	Carnitine palmitoyl transferase deficiency (I)	0.0773390694551354	-2.55955602474587	14	3	0.0410958904109589	73	992	3032,1376,2180	HADHB,CPT2,ACSL1
SMP00552	Glycogen synthetase deficiency	0.107134976912734	-2.23366577302642	16	3	0.0410958904109589	73	992	5836,283209,178	PYGL,PGM2L1,AGL
SMP00555	Glycogenosis- Type VI. Hers disease	0.107134976912734	-2.23366577302642	16	3	0.0410958904109589	73	992	5836,283209,178	PYGL,PGM2L1,AGL
SMP00058	Starch and Sucrose Metabolism	0.107134976912734	-2.23366577302642	16	3	0.0410958904109589	73	992	178,5836,283209	AGL,PYGL,PGM2L1
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.107134976912734	-2.23366577302642	16	3	0.0410958904109589	73	992	283209,5836,178	PGM2L1,PYGL,AGL
SMP00557	Sucrase-isomaltase deficiency	0.107134976912734	-2.23366577302642	16	3	0.0410958904109589	73	992	5836,178,283209	PYGL,AGL,PGM2L1
SMP00030	Oxidation of Branched Chain Fatty Acids	0.112049804364399	-2.18881182470372	8	2	0.0273972602739726	73	992	2180,1376	ACSL1,CPT2
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	0.112049804364399	-2.18881182470372	8	2	0.0273972602739726	73	992	2778,4638	GNAS,MYLK
SMP00415	Fentanyl Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00412	Oxymorphone Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,1812,773,481	CACNB1,DRD1,CACNA1A,ATP1B1
SMP00688	Naloxone Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,1812,773,782	ATP1B1,DRD1,CACNA1A,CACNB1
SMP00687	Naltrexone Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP00689	Dihydromorphine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00411	Hydrocodone Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00686	Pentazocine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00672	Propoxyphene Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,773,1812,481	CACNB1,CACNA1A,DRD1,ATP1B1
SMP00676	Dezocine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,773,1812,481	CACNB1,CACNA1A,DRD1,ATP1B1
SMP00677	Levomethadyl Acetate Action Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,1812,773,782	ATP1B1,DRD1,CACNA1A,CACNB1
SMP00678	Methadyl Acetate Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00404	Ropivacaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,773,1812,481	CACNB1,CACNA1A,DRD1,ATP1B1
SMP00400	Oxybuprocaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	1812,773,782,481	DRD1,CACNA1A,CACNB1,ATP1B1
SMP00681	Ethylmorphine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,1812,773,481	CACNB1,DRD1,CACNA1A,ATP1B1
SMP00680	Dimethylthiambutene Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,1812,773,481	CACNB1,DRD1,CACNA1A,ATP1B1
SMP00396	Dibucaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP00410	Hydromorphone Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP00393	Bupivacaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	1812,773,782,481	DRD1,CACNA1A,CACNB1,ATP1B1
SMP00674	Anileridine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,1812,773,481	CACNB1,DRD1,CACNA1A,ATP1B1
SMP00425	Escitalopram Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	773,1812,782,481	CACNA1A,DRD1,CACNB1,ATP1B1
SMP00401	Prilocaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00684	Buprenorphine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00413	Alfentanil Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,1812,773,481	CACNB1,DRD1,CACNA1A,ATP1B1
SMP00409	Oxycodone Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00416	Remifentanil Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00690	Ketobemidone  Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,773,1812,481	CACNB1,CACNA1A,DRD1,ATP1B1
SMP00392	Benzocaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP00673	Levorphanol Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,1812,773,782	ATP1B1,DRD1,CACNA1A,CACNB1
SMP00402	Procaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00417	Sufentanil Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,1812,773,782	ATP1B1,DRD1,CACNA1A,CACNB1
SMP00414	Carfentanil Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,773,1812,481	CACNB1,CACNA1A,DRD1,ATP1B1
SMP00671	Tramadol Action Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	773,1812,782,481	CACNA1A,DRD1,CACNB1,ATP1B1
SMP00679	3-Methylthiofentanyl Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00395	Cocaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP00397	Levobupivacaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	1812,773,782,481	DRD1,CACNA1A,CACNB1,ATP1B1
SMP00403	Proparacaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	1812,773,782,481	DRD1,CACNA1A,CACNB1,ATP1B1
SMP00394	Chloroprocaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	782,773,1812,481	CACNB1,CACNA1A,DRD1,ATP1B1
SMP00675	Diphenoxylate Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP00685	Alvimopan Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,1812,773,782	ATP1B1,DRD1,CACNA1A,CACNB1
SMP00683	Levallorphan Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00399	Mepivacaine Action Pathway	0.117569741312768	-2.14072357838757	26	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00691	Nalbuphine Action Pathway	0.130659496030596	-2.03516060668246	27	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00423	Desipramine Action Pathway	0.130659496030596	-2.03516060668246	27	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP00456	Fatty Acid Biosynthesis	0.141830913705036	-1.95311967944131	2	1	0.0136986301369863	73	992	31	ACACA
SMP00398	Lidocaine (Local Anaesthetic) Action Pathway	0.14433252479262	-1.93563544156215	28	4	0.0547945205479452	73	992	782,1812,773,481	CACNB1,DRD1,CACNA1A,ATP1B1
SMP00407	Heroin Action Pathway	0.158550205322742	-1.84168398299551	29	4	0.0547945205479452	73	992	1812,773,782,481	DRD1,CACNA1A,CACNB1,ATP1B1
SMP00405	Codeine Action Pathway	0.158550205322742	-1.84168398299551	29	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP02292	The oncogenic action of Succinate	0.173272131412351	-1.75289190643069	30	4	0.0547945205479452	73	992	1738,51660,3091,22992	DLD,MPC1,HIF1A,KDM2A
SMP00422	Imipramine Action Pathway	0.173272131412351	-1.75289190643069	30	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP02295	The oncogenic action of Fumarate	0.173272131412351	-1.75289190643069	30	4	0.0547945205479452	73	992	51660,1738,22992,3091	MPC1,DLD,KDM2A,HIF1A
SMP00426	Fluoxetine Action Pathway	0.188456561993813	-1.66888773900065	31	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	8565,2805	YARS,GOT1
SMP00206	Phenylketonuria	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2805,8565	GOT1,YARS
SMP00143	5-Oxoprolinuria	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2937,2729	GSS,GCLC
SMP00500	5-oxoprolinase deficiency	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2729,2937	GCLC,GSS
SMP00370	Tyrosinemia Type 3 (TYRO3)	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	8565,2805	YARS,GOT1
SMP00015	Glutathione Metabolism	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2937,2729	GSS,GCLC
SMP00337	Glutathione Synthetase Deficiency	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2937,2729	GSS,GCLC
SMP00501	Gamma-glutamyl-transpeptidase deficiency	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2729,2937	GCLC,GSS
SMP00008	Phenylalanine and Tyrosine Metabolism	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2805,8565	GOT1,YARS
SMP00183	Gamma-Glutamyltransferase Deficiency	0.191173675418136	-1.65457296871121	11	2	0.0273972602739726	73	992	2937,2729	GSS,GCLC
SMP00387	CHILD Syndrome	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	6713,10682,3157	SQLE,EBP,HMGCS1
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	10682,6713,3157	EBP,SQLE,HMGCS1
SMP00509	Hyper-IgD syndrome	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,6713,10682	HMGCS1,SQLE,EBP
SMP00117	Pamidronate Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,10682,6713	HMGCS1,EBP,SQLE
SMP00131	Atorvastatin Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	6713,10682,3157	SQLE,EBP,HMGCS1
SMP00510	Mevalonic aciduria	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	10682,6713,3157	EBP,SQLE,HMGCS1
SMP00196	Leigh Syndrome	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	31,97,1738	ACACA,ACYP1,DLD
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	31,97,1738	ACACA,ACYP1,DLD
SMP00092	Rosuvastatin Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	10682,6713,3157	EBP,SQLE,HMGCS1
SMP00348	Globoid Cell Leukodystrophy	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	7368,9517,2531	UGT8,SPTLC2,KDSR
SMP00525	Fabry disease	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	7368,9517,2531	UGT8,SPTLC2,KDSR
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	31,97,1738	ACACA,ACYP1,DLD
SMP00089	Pravastatin Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,6713,10682	HMGCS1,SQLE,EBP
SMP00559	Pyruvate kinase deficiency	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	1738,97,31	DLD,ACYP1,ACACA
SMP00112	Risedronate Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,10682,6713	HMGCS1,EBP,SQLE
SMP00209	Hypercholesterolemia	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,6713,10682	HMGCS1,SQLE,EBP
SMP00386	Desmosterolosis	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	10682,6713,3157	EBP,SQLE,HMGCS1
SMP00023	Steroid Biosynthesis	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,6713,10682	HMGCS1,SQLE,EBP
SMP00558	Primary hyperoxaluria II- PH2	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	1738,97,31	DLD,ACYP1,ACACA
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	6713,10682,3157	SQLE,EBP,HMGCS1
SMP00060	Pyruvate Metabolism	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	97,31,1738	ACYP1,ACACA,DLD
SMP00107	Zoledronate Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	6713,10682,3157	SQLE,EBP,HMGCS1
SMP00034	Sphingolipid Metabolism	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	7368,9517,2531	UGT8,SPTLC2,KDSR
SMP00099	Lovastatin Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,10682,6713	HMGCS1,EBP,SQLE
SMP00508	Cholesteryl ester storage disease	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	10682,6713,3157	EBP,SQLE,HMGCS1
SMP00082	Simvastatin Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,10682,6713	HMGCS1,EBP,SQLE
SMP00511	Wolman disease	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	10682,6713,3157	EBP,SQLE,HMGCS1
SMP00095	Alendronate Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,6713,10682	HMGCS1,SQLE,EBP
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,6713,10682	HMGCS1,SQLE,EBP
SMP00349	Gaucher Disease	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	2531,9517,7368	KDSR,SPTLC2,UGT8
SMP00119	Fluvastatin Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	6713,10682,3157	SQLE,EBP,HMGCS1
SMP00079	Ibandronate Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	6713,10682,3157	SQLE,EBP,HMGCS1
SMP00347	Metachromatic Leukodystrophy (MLD)	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	9517,2531,7368	SPTLC2,KDSR,UGT8
SMP00111	Cerivastatin Action Pathway	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	3157,6713,10682	HMGCS1,SQLE,EBP
SMP00526	Krabbe disease	0.19646863938999	-1.62725245638931	21	3	0.0410958904109589	73	992	2531,9517,7368	KDSR,SPTLC2,UGT8
SMP00408	Methadone Action Pathway	0.204060838582862	-1.58933710125179	32	4	0.0547945205479452	73	992	481,773,1812,782	ATP1B1,CACNA1A,DRD1,CACNB1
SMP00431	Nicotine Action Pathway	0.204060838582862	-1.58933710125179	32	4	0.0547945205479452	73	992	773,1812,782,481	CACNA1A,DRD1,CACNB1,ATP1B1
SMP00424	Citalopram Action Pathway	0.204060838582862	-1.58933710125179	32	4	0.0547945205479452	73	992	481,782,773,1812	ATP1B1,CACNB1,CACNA1A,DRD1
SMP00619	Felodipine Metabolism Pathway	0.205110048352774	-1.58420862264766	3	1	0.0136986301369863	73	992	782	CACNB1
SMP00124	Glycerol Phosphate Shuttle	0.205110048352774	-1.58420862264766	3	1	0.0136986301369863	73	992	2820	GPD2
SMP00554	Glycogenosis- Type IV. Amylopectinosis	0.219017606596026	-1.51860315698153	12	2	0.0273972602739726	73	992	178,283209	AGL,PGM2L1
SMP00553	Glycogenosis- Type III. Cori disease	0.219017606596026	-1.51860315698153	12	2	0.0273972602739726	73	992	283209,178	PGM2L1,AGL
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	0.236267188581315	-1.44279195935512	23	3	0.0410958904109589	73	992	1854,1635,1723	DUT,DCTD,DHODH
SMP00178	Dihydropyrimidinase Deficiency	0.236267188581315	-1.44279195935512	23	3	0.0410958904109589	73	992	1723,1635,1854	DHODH,DCTD,DUT
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	0.236267188581315	-1.44279195935512	23	3	0.0410958904109589	73	992	1723,1635,1854	DHODH,DCTD,DUT
SMP00172	Beta Ureidopropionase Deficiency	0.236267188581315	-1.44279195935512	23	3	0.0410958904109589	73	992	1723,1635,1854	DHODH,DCTD,DUT
SMP00046	Pyrimidine Metabolism	0.236267188581315	-1.44279195935512	23	3	0.0410958904109589	73	992	1635,1854,1723	DCTD,DUT,DHODH
SMP00090	Bendroflumethiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,9057,6339	ATP1B1,NR3C2,SLC7A6,SCNN1D
SMP00483	Kidney Function	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	9057,6339,481,4306	SLC7A6,SCNN1D,ATP1B1,NR3C2
SMP00118	Torsemide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,9057,6339	ATP1B1,NR3C2,SLC7A6,SCNN1D
SMP00091	Quinethazone Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	6339,9057,481,4306	SCNN1D,SLC7A6,ATP1B1,NR3C2
SMP00133	Amiloride Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,9057,6339	ATP1B1,NR3C2,SLC7A6,SCNN1D
SMP00583	Blue diaper syndrome	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,9057,6339	ATP1B1,NR3C2,SLC7A6,SCNN1D
SMP00080	Polythiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,6339,9057	NR3C2,ATP1B1,SCNN1D,SLC7A6
SMP00132	Triamterene Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	6339,9057,481,4306	SCNN1D,SLC7A6,ATP1B1,NR3C2
SMP00193	Iminoglycinuria	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	6339,9057,481,4306	SCNN1D,SLC7A6,ATP1B1,NR3C2
SMP00134	Spironolactone Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	9057,6339,4306,481	SLC7A6,SCNN1D,NR3C2,ATP1B1
SMP00103	Cyclothiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,6339,9057	ATP1B1,NR3C2,SCNN1D,SLC7A6
SMP00197	Lysinuric Protein Intolerance	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	9057,6339,4306,481	SLC7A6,SCNN1D,NR3C2,ATP1B1
SMP00723	Cystinuria	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,9057,6339	NR3C2,ATP1B1,SLC7A6,SCNN1D
SMP00245	Glucose Transporter Defect (SGLT2)	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,6339,9057	NR3C2,ATP1B1,SCNN1D,SLC7A6
SMP00108	Hydroflumethiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,6339,9057	ATP1B1,NR3C2,SCNN1D,SLC7A6
SMP00105	Metolazone Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,9057,6339	NR3C2,ATP1B1,SLC7A6,SCNN1D
SMP00097	Ethacrynic Acid Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,6339,9057	ATP1B1,NR3C2,SCNN1D,SLC7A6
SMP00189	Hartnup Disorder	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,6339,9057	NR3C2,ATP1B1,SCNN1D,SLC7A6
SMP00078	Chlorothiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,9057,6339	ATP1B1,NR3C2,SLC7A6,SCNN1D
SMP00088	Bumetanide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	9057,6339,4306,481	SLC7A6,SCNN1D,NR3C2,ATP1B1
SMP00585	Lysinuric protein intolerance (LPI)	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,6339,9057	ATP1B1,NR3C2,SCNN1D,SLC7A6
SMP00110	Indapamide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,6339,9057	NR3C2,ATP1B1,SCNN1D,SLC7A6
SMP00100	Hydrochlorothiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,6339,9057	NR3C2,ATP1B1,SCNN1D,SLC7A6
SMP00135	Eplerenone Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	6339,9057,4306,481	SCNN1D,SLC7A6,NR3C2,ATP1B1
SMP00184	Glucose Transporter Defect (SGLT2)	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	4306,481,9057,6339	NR3C2,ATP1B1,SLC7A6,SCNN1D
SMP00081	Methyclothiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,6339,9057	ATP1B1,NR3C2,SCNN1D,SLC7A6
SMP00121	Trichlormethiazide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	6339,9057,481,4306	SCNN1D,SLC7A6,ATP1B1,NR3C2
SMP00122	Chlorthalidone Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	481,4306,9057,6339	ATP1B1,NR3C2,SLC7A6,SCNN1D
SMP00115	Furosemide Action Pathway	0.236355984908217	-1.44241619983706	34	4	0.0547945205479452	73	992	6339,9057,481,4306	SCNN1D,SLC7A6,ATP1B1,NR3C2
SMP00446	Gemcitabine Action Pathway	0.247192152170247	-1.39758930078666	13	2	0.0273972602739726	73	992	2030,1635	SLC29A1,DCTD
SMP00603	Gemcitabine Metabolism Pathway	0.247192152170247	-1.39758930078666	13	2	0.0273972602739726	73	992	1635,2030	DCTD,SLC29A1
SMP00076	Thiamine Metabolism	0.263782410810337	-1.3326307171526	4	1	0.0136986301369863	73	992	79178	THTPA
SMP00281	Anistreplase Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00282	Streptokinase Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00279	Ximelagatran Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00278	Lepirudin Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00586	Coagulation 	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00269	Acenocoumarol Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00270	Dicumarol Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00276	Argatroban Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00048	Nicotinate and Nicotinamide Metabolism	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	10135,55191	NAMPT,NADSYN1
SMP00284	Urokinase Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00283	Tenecteplase Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00288	Aprotinin Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00655	Phenindione Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00271	Phenprocoumon Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00286	Aminocaproic Acid Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00268	Warfarin Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00285	Reteplase Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00277	Bivalirudin Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00287	Tranexamic Acid Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00280	Alteplase Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00656	Dicoumarol Action Pathway	0.275500999289545	-1.28916402321046	14	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP02291	The oncogenic action of 2-hydroxyglutarate	0.298208356414604	-1.20996285419167	26	3	0.0410958904109589	73	992	1738,51660,22992	DLD,MPC1,KDM2A
SMP00273	Fondaparinux Action Pathway	0.303774220991838	-1.19147054761561	15	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00272	Enoxaparin Action Pathway	0.303774220991838	-1.19147054761561	15	2	0.0273972602739726	73	992	2157,2159	F8,F10
SMP00275	Ardeparin Action Pathway	0.303774220991838	-1.19147054761561	15	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00274	Heparin Action Pathway	0.303774220991838	-1.19147054761561	15	2	0.0273972602739726	73	992	2159,2157	F10,F8
SMP00465	Carnitine Synthesis	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	8424	BBOX1
SMP00352	Primary Hyperoxaluria Type I	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	2875	GPT
SMP00313	Lactic Acidemia	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	2875	GPT
SMP00055	Alanine Metabolism	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	2875	GPT
SMP00021	Taurine and Hypotaurine Metabolism	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	2571	GAD1
SMP00350	Pyruvate Carboxylase Deficiency	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	2875	GPT
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	9415	FADS2
SMP00070	Riboflavin Metabolism	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	80308	FLAD1
SMP00310	Corticotropin Activation of Cortisol Production	0.318179054546649	-1.14514099005126	5	1	0.0136986301369863	73	992	2778	GNAS
SMP00406	Morphine Action Pathway	0.338862417036057	-1.08216110343203	40	4	0.0547945205479452	73	992	481,782,1812,773	ATP1B1,CACNB1,DRD1,CACNA1A
SMP02358	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	0.340130296663625	-1.07842650930281	28	3	0.0410958904109589	73	992	22992,1738,51660	KDM2A,DLD,MPC1
SMP02359	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	0.361081845664672	-1.01865062705347	29	3	0.0410958904109589	73	992	51660,1738,22992	MPC1,DLD,KDM2A
SMP00445	Spermidine and Spermine Biosynthesis	0.368607554058773	-0.998022740036787	6	1	0.0136986301369863	73	992	6611	SMS
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	0.368607554058773	-0.998022740036787	6	1	0.0136986301369863	73	992	2778	GNAS
SMP00478	Nucleotide Excision Repair 	0.368607554058773	-0.998022740036787	6	1	0.0136986301369863	73	992	2068	ERCC2
SMP00654	Warburg Effect	0.408703622999968	-0.894765023758346	44	4	0.0547945205479452	73	992	2023,5315,51660,1738	ENO1,PKM,MPC1,DLD
SMP00322	Vasopressin Regulation of Water Homeostasis	0.415353647927542	-0.87862495795594	7	1	0.0136986301369863	73	992	2778	GNAS
SMP00054	Fatty Acid Elongation In Mitochondria	0.415353647927542	-0.87862495795594	7	1	0.0136986301369863	73	992	3032	HADHB
SMP00634	Carbamazepine Metabolism Pathway	0.415353647927542	-0.87862495795594	7	1	0.0136986301369863	73	992	2052	EPHX1
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	0.415353647927542	-0.87862495795594	7	1	0.0136986301369863	73	992	3032	HADHB
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00360	Hyperprolinemia Type II	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00551	Pyruvate dehydrogenase deficiency (E2)	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	51660,1738	MPC1,DLD
SMP00548	Mitochondrial complex II deficiency	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	1738,51660	DLD,MPC1
SMP00020	Arginine and Proline Metabolism	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	8659,2805	ALDH4A1,GOT1
SMP00546	Congenital lactic acidosis	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	1738,51660	DLD,MPC1
SMP00361	Hyperprolinemia Type I	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00550	Pyruvate dehydrogenase deficiency (E3)	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	1738,51660	DLD,MPC1
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00057	Citric Acid Cycle	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	51660,1738	MPC1,DLD
SMP00207	Prolidase Deficiency (PD)	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	8659,2805	ALDH4A1,GOT1
SMP00507	L-arginine:glycine amidinotransferase deficiency	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00547	Fumarase deficiency	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	51660,1738	MPC1,DLD
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	1738,51660	DLD,MPC1
SMP00208	Prolinemia Type II	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	0.440181300050362	-0.820568591368289	20	2	0.0273972602739726	73	992	2805,8659	GOT1,ALDH4A1
SMP00127	Glucose-Alanine Cycle	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	2875	GPT
SMP00491	Sepiapterin reductase deficiency	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	1719	DHFR
SMP00005	Pterine Biosynthesis	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	1719	DHFR
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	1719	DHFR
SMP00466	Transfer of Acetyl Groups into Mitochondria	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	51660	MPC1
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	3032	HADHB
SMP00490	Segawa syndrome	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	1719	DHFR
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	1719	DHFR
SMP00486	Dopa-responsive dystonia	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	1719	DHFR
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	0.45868276843679	-0.779396444169678	8	1	0.0136986301369863	73	992	1719	DHFR
SMP00574	Glycogenosis- Type IC	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	2023,51660	ENO1,MPC1
SMP00573	Glycogenosis- Type IB	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	51660,2023	MPC1,ENO1
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	2023,51660	ENO1,MPC1
SMP00563	Triosephosphate isomerase	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	51660,2023	MPC1,ENO1
SMP00128	Gluconeogenesis	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	2023,51660	ENO1,MPC1
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	2023,51660	ENO1,MPC1
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	2023,51660	ENO1,MPC1
SMP00562	Fructose-1-6-diphosphatase deficiency	0.49080230474683	-0.711713870258221	22	2	0.0273972602739726	73	992	51660,2023	MPC1,ENO1
SMP00351	GABA-Transaminase Deficiency	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2571	GAD1
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2778	GNAS
SMP00007	Beta-Alanine Metabolism	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2571	GAD1
SMP00492	Ureidopropionase deficiency	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2571	GAD1
SMP00452	Threonine and 2-Oxobutanoate Degradation	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	1738	DLD
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2778	GNAS
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2778	GNAS
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2778	GNAS
SMP00716	Thyroid hormone synthesis	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	53905	DUOX1
SMP00493	Carnosinuria- carnosinemia	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2571	GAD1
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	0.498841465494859	-0.69546693812848	9	1	0.0136986301369863	73	992	2778	GNAS
SMP00327	Phenytoin (Antiarrhythmic) Action Pathway	0.507846830960309	-0.677575390725756	77	6	0.0821917808219178	73	992	2052,782,5573,4638,481,54578	EPHX1,CACNB1,PRKAR1A,MYLK,ATP1B1,UGT1A6
SMP00438	Vindesine Action Pathway	0.536058732046163	-0.623511549201214	10	1	0.0136986301369863	73	992	7157	TP53
SMP00437	Vincristine Action Pathway	0.536058732046163	-0.623511549201214	10	1	0.0136986301369863	73	992	7157	TP53
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	0.536058732046163	-0.623511549201214	10	1	0.0136986301369863	73	992	2778	GNAS
SMP00039	Glycerolipid Metabolism	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	2820	GPD2
SMP00187	Glycerol Kinase Deficiency	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	2820	GPD2
SMP00529	D-glyceric acidura	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	2820	GPD2
SMP00635	Valproic Acid Metabolism Pathway	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	3032	HADHB
SMP00009	Ammonia Recycling	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	1738	DLD
SMP00439	Vinorelbine Action Pathway	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	7157	TP53
SMP00436	Vinblastine Action Pathway	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	7157	TP53
SMP00530	Familial lipoprotein lipase deficiency	0.570547237710185	-0.561159312564075	11	1	0.0136986301369863	73	992	2820	GPD2
SMP00494	Tyrosinemia- transient	0.602504476902503	-0.50666018310136	12	1	0.0136986301369863	73	992	2805	GOT1
SMP00457	Lactose Degradation	0.602504476902503	-0.50666018310136	12	1	0.0136986301369863	73	992	481	ATP1B1
SMP00458	Lactose Intolerance	0.602504476902503	-0.50666018310136	12	1	0.0136986301369863	73	992	481	ATP1B1
SMP00659	Timolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00377	Felodipine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00669	Practolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00297	Alprenolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	782,4638,5573,481	CACNB1,MYLK,PRKAR1A,ATP1B1
SMP00306	Pindolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00662	Dobutamine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	782,5573,4638,481	CACNB1,PRKAR1A,MYLK,ATP1B1
SMP00305	Penbutolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	4638,5573,782,481	MYLK,PRKAR1A,CACNB1,ATP1B1
SMP00324	Procainamide (Antiarrhythmic) Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	782,5573,4638,481	CACNB1,PRKAR1A,MYLK,ATP1B1
SMP00299	Betaxolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00382	Nitrendipine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,5573,4638	ATP1B1,CACNB1,PRKAR1A,MYLK
SMP00664	Arbutamine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00660	Sotalol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00666	Levobunolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00307	Propranolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00375	Verapamil Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00325	Disopyramide Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	782,4638,5573,481	CACNB1,MYLK,PRKAR1A,ATP1B1
SMP00300	Bisoprolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,5573,4638	ATP1B1,CACNB1,PRKAR1A,MYLK
SMP00380	Nimodipine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00332	Ibutilide Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00330	Tocainide Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00298	Atenolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00329	Mexiletine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00379	Nifedipine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	4638,5573,782,481	MYLK,PRKAR1A,CACNB1,ATP1B1
SMP00381	Nisoldipine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00359	Diltiazem Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00667	Metipranolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00378	Isradipine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00331	Flecainide Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00323	Quinidine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00301	Esmolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00663	Isoprenaline Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00665	Amiodarone Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00668	Bevantolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	4638,5573,782,481	MYLK,PRKAR1A,CACNB1,ATP1B1
SMP00588	Muscle/Heart Contraction	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00326	Fosphenytoin (Antiarrhythmic) Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00366	Nebivolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00296	Acebutolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,5573,4638	ATP1B1,CACNB1,PRKAR1A,MYLK
SMP00304	Oxprenolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00661	Epinephrine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00376	Amlodipine Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00658	Carteolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,5573,4638,782	ATP1B1,PRKAR1A,MYLK,CACNB1
SMP00303	Nadolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,4638,5573,782	ATP1B1,MYLK,PRKAR1A,CACNB1
SMP00670	Bupranolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00302	Metoprolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	782,4638,5573,481	CACNB1,MYLK,PRKAR1A,ATP1B1
SMP00657	Bopindolol Action Pathway	0.618477104219476	-0.480495106073305	57	4	0.0547945205479452	73	992	481,782,4638,5573	ATP1B1,CACNB1,MYLK,PRKAR1A
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	2875	GPT
SMP00571	Pyridoxine dependency with seizures	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	1738	DLD
SMP00186	Glutaric Aciduria Type I	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	1738	DLD
SMP00467	Trehalose Degradation	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	481	ATP1B1
SMP00719	2-aminoadipic 2-oxoadipic aciduria	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	1738	DLD
SMP00528	Hyperlysinemia II or Saccharopinuria	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	1738	DLD
SMP00059	Urea Cycle	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	2875	GPT
SMP00037	Lysine Degradation	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	1738	DLD
SMP00003	Argininosuccinic Aciduria	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	2875	GPT
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	2875	GPT
SMP00527	Hyperlysinemia I- Familial	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	1738	DLD
SMP00001	Citrullinemia Type I	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	2875	GPT
SMP00239	Saccharopinuria/Hyperlysinemia II	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	1738	DLD
SMP00357	Argininemia	0.632113837297589	-0.458685778749043	13	1	0.0136986301369863	73	992	2875	GPT
SMP00368	Labetalol Action Pathway	0.63269897520191	-0.457760522552579	58	4	0.0547945205479452	73	992	782,5573,4638,481	CACNB1,PRKAR1A,MYLK,ATP1B1
SMP00367	Carvedilol Action Pathway	0.63269897520191	-0.457760522552579	58	4	0.0547945205479452	73	992	481,782,5573,4638	ATP1B1,CACNB1,PRKAR1A,MYLK
SMP00328	Lidocaine (Antiarrhythmic) Action Pathway	0.646588624164938	-0.436045007156831	59	4	0.0547945205479452	73	992	5573,4638,782,481	PRKAR1A,MYLK,CACNB1,ATP1B1
SMP00192	Hypoacetylaspartia	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	2571	GAD1
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	31	ACACA
SMP00198	Malonic Aciduria	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	31	ACACA
SMP00067	Aspartate Metabolism	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	2571	GAD1
SMP00044	Histidine Metabolism	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	3067	HDC
SMP00016	Propanoate Metabolism	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	31	ACACA
SMP00175	Canavan Disease	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	2571	GAD1
SMP00502	Malonyl-coa decarboxylase deficiency	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	31	ACACA
SMP00191	Histidinemia	0.659545594067848	-0.416204174918985	14	1	0.0136986301369863	73	992	3067	HDC
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00238	Isovaleric Aciduria	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00199	Maple Syrup Urine Disease	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00200	Methylmalonic Aciduria	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00139	3-Methylglutaconic Aciduria Type I	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00140	3-Methylglutaconic Aciduria Type III	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00236	Propionic Acidemia	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00141	3-Methylglutaconic Aciduria Type IV	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00522	3-hydroxyisobutyric aciduria	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	1738,56922	DLD,MCCC1
SMP00524	Isovaleric acidemia	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00032	Valine- Leucine and Isoleucine Degradation	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00173	Beta-Ketothiolase Deficiency	0.662845408447978	-0.411213485746292	30	2	0.0273972602739726	73	992	56922,1738	MCCC1,DLD
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	64080	RBKS
SMP00040	Glycolysis	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	2023	ENO1
SMP00024	Porphyrin Metabolism	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	3145	HMBS
SMP00346	Porphyria Variegata (PV)	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	3145	HMBS
SMP00344	Acute Intermittent Porphyria	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	3145	HMBS
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	3145	HMBS
SMP00031	Pentose Phosphate Pathway	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	64080	RBKS
SMP00609	Mercaptopurine Metabolism Pathway	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	2030	SLC29A1
SMP00520	Transaldolase deficiency	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	64080	RBKS
SMP00531	Glycogenosis- Type VII. Tarui disease	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	2023	ENO1
SMP00519	Ribose-5-phosphate isomerase deficiency	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	64080	RBKS
SMP00342	Hereditary Coproporphyria (HCP)	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	3145	HMBS
SMP00572	Fanconi-bickel syndrome	0.684957835003677	-0.378397997353641	15	1	0.0136986301369863	73	992	2023	ENO1
SMP00427	Azathioprine Action Pathway	0.688452822340695	-0.373308485542173	47	3	0.0410958904109589	73	992	2030,10606,2618	SLC29A1,PAICS,GART
SMP00428	Mercaptopurine Action Pathway	0.688452822340695	-0.373308485542173	47	3	0.0410958904109589	73	992	2030,10606,2618	SLC29A1,PAICS,GART
SMP00430	Thioguanine Action Pathway	0.688452822340695	-0.373308485542173	47	3	0.0410958904109589	73	992	2030,10606,2618	SLC29A1,PAICS,GART
SMP00498	Dopamine beta-hydroxylase deficiency	0.730300287987223	-0.314299476015163	17	1	0.0136986301369863	73	992	2805	GOT1
SMP00190	Hawkinsinuria	0.730300287987223	-0.314299476015163	17	1	0.0136986301369863	73	992	2805	GOT1
SMP00218	Tyrosinemia Type I	0.730300287987223	-0.314299476015163	17	1	0.0136986301369863	73	992	2805	GOT1
SMP00006	Tyrosine Metabolism	0.730300287987223	-0.314299476015163	17	1	0.0136986301369863	73	992	2805	GOT1
SMP00169	Alkaptonuria	0.730300287987223	-0.314299476015163	17	1	0.0136986301369863	73	992	2805	GOT1
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	0.730300287987223	-0.314299476015163	17	1	0.0136986301369863	73	992	2805	GOT1
SMP02298	Glutaminolysis and Cancer	0.74499712862832	-0.29437491480018	35	2	0.0273972602739726	73	992	51660,1738	MPC1,DLD
SMP00561	Fructosuria	0.750493189503264	-0.287024702562369	18	1	0.0136986301369863	73	992	7264	TSTA3
SMP00064	Fructose and Mannose Degradation	0.750493189503264	-0.287024702562369	18	1	0.0136986301369863	73	992	7264	TSTA3
SMP00725	Fructose intolerance- hereditary	0.750493189503264	-0.287024702562369	18	1	0.0136986301369863	73	992	7264	TSTA3
SMP00341	Hypermethioninemia	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00177	Cystathionine Beta-Synthase Deficiency	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00222	Glycine N-methyltransferase Deficiency	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00355	Mitochondrial Electron Transport Chain	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	2820	GPD2
SMP00221	Methionine Adenosyltransferase Deficiency	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00033	Methionine Metabolism	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.769193391934132	-0.262412856133675	19	1	0.0136986301369863	73	992	4524	MTHFR
SMP00537	Myoadenylate deaminase deficiency	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	2618,10606	GART,PAICS
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00203	Molybdenum Cofactor Deficiency	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00365	Gout or Kelley-Seegmiller Syndrome	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	2618,10606	GART,PAICS
SMP00210	Purine Nucleoside Phosphorylase Deficiency	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	2618,10606	GART,PAICS
SMP00512	Xanthinuria type I	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00167	Adenylosuccinate Lyase Deficiency	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00513	Xanthinuria type II	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	2618,10606	GART,PAICS
SMP00364	Lesch-Nyhan Syndrome (LNS)	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00536	Mitochondrial DNA depletion syndrome	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	2618,10606	GART,PAICS
SMP00168	AICA-Ribosiduria	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00050	Purine Metabolism	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	2618,10606	GART,PAICS
SMP00144	Adenosine Deaminase Deficiency	0.772814643617181	-0.257716047483359	37	2	0.0273972602739726	73	992	10606,2618	PAICS,GART
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	0.785722854231599	-0.24115115149068	38	2	0.0273972602739726	73	992	8874,2778	ARHGEF7,GNAS
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	0.785722854231599	-0.24115115149068	38	2	0.0273972602739726	73	992	8874,2778	ARHGEF7,GNAS
SMP00429	Disulfiram Action Pathway	0.843853094177207	-0.169776858567957	24	1	0.0136986301369863	73	992	2805	GOT1
SMP00484	Dimethylglycine Dehydrogenase Deficiency	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00004	Glycine and Serine Metabolism	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00242	Dimethylglycine Dehydrogenase Deficiency	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00485	Hyperglycinemia- non-ketotic	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00223	Non Ketotic Hyperglycinemia	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00721	3-Phosphoglycerate dehydrogenase deficiency	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00244	Sarcosinemia	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	1738	DLD
SMP00025	Phospholipid Biosynthesis	0.866527404606801	-0.143261543544364	26	1	0.0136986301369863	73	992	2820	GPD2
SMP00640	Acetaminophen Metabolism Pathway	0.885947718070829	-0.121097339067555	28	1	0.0136986301369863	73	992	54578	UGT1A6
SMP00074	Retinol Metabolism	0.934396063631991	-0.0678548796396608	35	1	0.0136986301369863	73	992	9227	LRAT
SMP00336	Vitamin A Deficiency	0.934396063631991	-0.0678548796396608	35	1	0.0136986301369863	73	992	9227	LRAT
SMP00514	Gamma-cystathionase deficiency (CTH)	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00455	Homocysteine Degradation	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00614	Lansoprazole Metabolism Pathway	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00615	Pantoprazole Metabolism Pathway	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00616	Rabeprazole Metabolism Pathway	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00612	Esomeprazole Metabolism Pathway	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00613	Omeprazole Metabolism Pathway	0.999999999998251	-1.74869146940537e-12	2	0	0	73	992
SMP00653	Rosiglitazone Metabolism Pathway	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00472	Erlotinib Action Pathway	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00459	Pyruvaldehyde Degradation	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00626	Desipramine Metabolism Pathway	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00464	Vitamin K Metabolism	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00066	Biotin Metabolism	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00420	Bevacizumab Action Pathway	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00126	Phenylacetate Metabolism	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00174	Biotinidase Deficiency	0.999999999999538	-4.62427676446026e-13	3	0	0	73	992
SMP00475	Panitumumab Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00599	Trandolapril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00267	Tirofiban Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00476	Trastuzumab Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00732	Temocapril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00263	Cilostazol Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00611	Ticlopidine Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00631	Prednisone Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00264	Dipyridamole (Antiplatelet) Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00597	Ramipril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00470	Fluorouracil Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00440	Prednisone Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00473	Gefitinib Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00638	Levomethadyl Acetate Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00261	Ticlopidine Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00593	Enalapril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00598	Spirapril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00036	D-Arginine and D-Ornithine Metabolism	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00441	Prednisolone Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00266	Eptifibatide Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00474	Cetuximab Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00594	Fosinopril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00595	Moexipril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00608	Fluorouracil Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00592	Cilazapril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00596	Quinapril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00647	Thioguanine Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00617	Cimetidine Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00591	Benazepril Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00265	Abciximab Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00632	Prednisolone Metabolism Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00421	Vatalanib Action Pathway	0.999999999999918	-8.21148704588381e-14	1	0	0	73	992
SMP00159	Eprosartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00602	Teniposide Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00620	Lidocaine (Local Anaesthetic) Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00145	Benazepril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00450	Phytanic Acid Peroxisomal Oxidation	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00451	Refsum Disease	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00150	Lisinopril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00733	Temocapril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00156	Spirapril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00618	Fosphenytoin (Antiarrhythmic) Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00155	Rescinnamine Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00157	Trandolapril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00161	Irbesartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00146	Captopril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00497	Tyrosine hydroxylase deficiency	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00158	Candesartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00621	Codeine Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00154	Ramipril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00587	Angiotensin Metabolism	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00165	Valsartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00012	Catecholamine Biosynthesis	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00065	Ubiquinone Biosynthesis	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00152	Perindopril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00129	Malate-Aspartate Shuttle	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00147	Cilazapril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00162	Losartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00639	Clomipramine Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00629	Adefovir Dipivoxil Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00633	Felbamate Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00153	Quinapril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00149	Fosinopril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00479	Plasmalogen Synthesis	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00160	Forasartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00163	Olmesartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00623	Heroin Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00164	Telmisartan Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00651	Artemether Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00148	Enalapril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00630	Tenofovir Metabolism Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00151	Moexipril Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00443	Teniposide Action Pathway	0.999999999999983	-1.66147409957733e-14	4	0	0	73	992
SMP00503	Hypophosphatasia	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00607	Capecitabine Metabolism Pathway	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00641	Doxepin Metabolism Pathway	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00468	Degradation of Superoxides	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00071	Ketone Body Metabolism	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00469	Capecitabine Action Pathway	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00017	Vitamin B6 Metabolism	1.00000000000033	3.31431630450017e-13	5	0	0	73	992
SMP00027	Pantothenate and CoA Biosynthesis	1.00000000000091	9.11671860282818e-13	6	0	0	73	992
SMP00625	Imipramine Metabolism Pathway	1.00000000000091	9.11671860282818e-13	6	0	0	73	992
SMP00646	Fluoxetine Metabolism Pathway	1.00000000000091	9.11671860282818e-13	6	0	0	73	992
SMP00636	Venlafaxine Metabolism Pathway	1.00000000000091	9.11671860282818e-13	6	0	0	73	992
SMP00628	Nicotine Metabolism Pathway	1.00000000000091	9.11671860282818e-13	6	0	0	73	992
SMP00434	Paclitaxel Action Pathway	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00041	Sulfate/Sulfite Metabolism	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00682	Leucine Stimulation on Insulin Signaling	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00532	Sulfite oxidase deficiency	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00449	Ethanol Degradation	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00627	Citalopram Metabolism Pathway	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00637	Tramadol Metabolism Pathway	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00435	Docetaxel Action Pathway	1.00000000000147	1.47225125328977e-12	7	0	0	73	992
SMP00028	Caffeine Metabolism	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00642	Nevirapine Metabolism Pathway	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00644	Celecoxib Metabolism Pathway	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00010	Nucleotide Sugars Metabolism	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00073	Butyrate Metabolism	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00123	Betaine Metabolism	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00495	Galactosemia II (GALK)	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00605	Ifosfamide Metabolism Pathway	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00496	Galactosemia III	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00448	Ifosfamide Action Pathway	1.00000000000215	2.14776938733279e-12	8	0	0	73	992
SMP00225	Esomeprazole Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00229	Rabeprazole Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00233	Nizatidine Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00246	Pirenzepine Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00444	Lactose Synthesis	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00230	Ranitidine Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00447	Cyclophosphamide Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00227	Lansoprazole Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00226	Omeprazole Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00589	Gastric Acid Production	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00734	Roxatidine acetate Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00579	Congenital disorder of glycosylation CDG-IId	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00260	Clopidogrel Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00228	Pantoprazole Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00231	Famotidine Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00610	Clopidogrel Metabolism Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00580	GLUT-1 deficiency syndrome	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00735	Metiamide Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00604	Cyclophosphamide Metabolism Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00736	Betazole Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00232	Cimetidine Action Pathway	1.0000000000028	2.79554997413074e-12	9	0	0	73	992
SMP00624	Methadone Metabolism Pathway	1.00000000000381	3.80714738748008e-12	10	0	0	73	992
SMP00606	Tamoxifen Metabolism Pathway	1.00000000000381	3.80714738748008e-12	10	0	0	73	992
SMP00471	Tamoxifen Action Pathway	1.00000000000381	3.80714738748008e-12	10	0	0	73	992
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	1.00000000000473	4.72787745559522e-12	12	0	0	73	992
SMP00565	Aromatase deficiency	1.00000000000473	4.72787745559522e-12	12	0	0	73	992
SMP00068	Androgen and Estrogen Metabolism	1.00000000000473	4.72787745559522e-12	12	0	0	73	992
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00718	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00576	21-hydroxylase deficiency (CYP21)	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00130	Steroidogenesis	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00029	Selenoamino Acid Metabolism	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00391	Insulin Signalling	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00717	Apparent mineralocorticoid excess syndrome	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.0000000000051	5.09685873383145e-12	11	0	0	73	992
SMP00043	Galactose Metabolism	1.0000000000052	5.19902272227781e-12	13	0	0	73	992
SMP02313	sarcosine oncometabolite pathway 	1.0000000000052	5.19902272227781e-12	13	0	0	73	992
SMP00182	Galactosemia	1.0000000000052	5.19902272227781e-12	13	0	0	73	992
SMP00648	Sorafenib Metabolism Pathway	1.00000000000612	6.12249929800898e-12	14	0	0	73	992
SMP00462	Inositol Phosphate Metabolism	1.00000000000612	6.12249929800898e-12	14	0	0	73	992
SMP00622	Morphine Metabolism Pathway	1.00000000000784	7.83832154070722e-12	15	0	0	73	992
SMP00652	Mycophenolic Acid Metabolism Pathway	1.00000000000886	8.85944857683226e-12	16	0	0	73	992
SMP00035	Bile Acid Biosynthesis	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00314	Congenital Bile Acid Synthesis Defect Type II	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00318	Congenital Bile Acid Synthesis Defect Type III	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00650	Doxorubicin Metabolism Pathway	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00720	27-Hydroxylase Deficiency	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00317	Familial Hypercholanemia (FHCA)	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00316	Zellweger Syndrome	1.00000000001047	1.0469978396291e-11	17	0	0	73	992
SMP00442	Etoposide Action Pathway	1.00000000001072	1.072372017175e-11	18	0	0	73	992
SMP00649	Lamivudine Metabolism Pathway	1.00000000001072	1.072372017175e-11	18	0	0	73	992
SMP00601	Etoposide Metabolism Pathway	1.00000000001072	1.072372017175e-11	18	0	0	73	992
SMP00063	Tryptophan Metabolism	1.00000000001129	1.12891241462312e-11	19	0	0	73	992
SMP00463	Phosphatidylinositol Phosphate Metabolism	1.00000000001283	1.28253111749229e-11	20	0	0	73	992
SMP00582	Joubert syndrome	1.00000000001283	1.28253111749229e-11	20	0	0	73	992
SMP00590	Ibuprofen Metabolism Pathway	1.00000000001283	1.28331201934061e-11	22	0	0	73	992
SMP00433	Irinotecan Action Pathway	1.00000000001315	1.31518476499414e-11	21	0	0	73	992
SMP00600	Irinotecan Metabolism Pathway	1.00000000001315	1.31518476499414e-11	21	0	0	73	992
SMP00011	Inositol Metabolism	1.00000000001315	1.31518476499414e-11	21	0	0	73	992
SMP00075	Arachidonic Acid Metabolism	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00706	Tenoxicam Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00701	Phenylbutazone Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00705	Tiaprofenic Acid Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00693	Antrafenine Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00120	Naproxen Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00696	Fenoprofen Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00289	Diflunisal Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00101	Suprofen Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00084	Etodolac Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00102	Bromfenac Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00094	Sulindac Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00704	Tolmetin Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00116	Valdecoxib Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00106	Meloxicam Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00098	Ketorolac Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00710	Acetaminophen  Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00699	Lumiracoxib Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00113	Oxaprozin Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00695	Etoricoxib Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00703	Trisalicylate-choline Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00700	Lornoxicam Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00353	Leukotriene C4 Synthesis Deficiency	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00692	Antipyrine Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00085	Ketoprofen Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00087	Rofecoxib Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00698	Magnesium salicylate Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00109	Mefenamic Acid Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00093	Diclofenac Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00709	Salicylic Acid Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00114	Nabumetone Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00702	Nepafenac Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00083	Acetylsalicylic Acid Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00077	Piroxicam Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00694	Carprofen Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00697	Flurbiprofen Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00707	Salsalate Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00708	Salicylate-sodium Action Pathway	1.00000000001827	1.82722860537561e-11	28	0	0	73	992
SMP00104	Indomethacin Action Pathway	1.00000000001866	1.86623426500983e-11	29	0	0	73	992
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	1.00000000002048	2.04806912519971e-11	32	0	0	73	992
SMP00096	Celecoxib Action Pathway	1.00000000002124	2.12401000108818e-11	34	0	0	73	992
SMP00086	Ibuprofen Action Pathway	1.00000000002835	2.83454531828044e-11	47	0	0	73	992
